I am BIO Podcast: Accelerated Approval, accelerating hope
The Accelerated Approval pathway was established by the U.S. Food and Drug Administration…
Drug-resistant C. auris fungi cases tripled in 2021 says CDC
According to a recent report from the Centers for Disease Control and Prevention…
HHS investigating using Bayh-Dole march-in rights for price controls
The Department of Health and Human Services (HHS) and Department of Commerce (DOC)…
Biotech corn in the spotlight; USTR pledges to use all USMCA tools
Following her appearance before the Senate Finance Committee on Thursday, U.S. Trade Representative…
PBM Transparency Act now heads to full Senate
The Senate Commerce Committee approved legislation yesterday which prohibits pharmacy benefit managers (PBMs)…
Mexico corn ban and TRIPS waiver dominate discussion in USTR hearing
During a hearing Thursday, March 23, members of the Senate Finance Committee urged…
EDITORS’ CHOICE
4 questions with Moderna President Stephen Hoge
On Wednesday, Moderna’s CEO will testify before the Senate Health, Education, Labor, and Pensions (HELP) Committee in a hearing with…
Read more
Latest News
I am BIO Podcast: Accelerated Approval, accelerating hope
The Accelerated Approval pathway was established by the U.S. Food and Drug Administration (FDA) in the 1990s to boost R&D…
Drug-resistant C. auris fungi cases tripled in 2021 says CDC
According to a recent report from the Centers for Disease Control and Prevention (CDC), drug-resistant Candida auris (C. auris) fungus…
HHS investigating using Bayh-Dole march-in rights for price controls
The Department of Health and Human Services (HHS) and Department of Commerce (DOC) will investigate using Bayh-Dole march-in rights as…
Biotech corn in the spotlight; USTR pledges to use all USMCA tools
Following her appearance before the Senate Finance Committee on Thursday, U.S. Trade Representative Ambassador Katherine Tai revisited the administration’s trade…
PBM Transparency Act now heads to full Senate
The Senate Commerce Committee approved legislation yesterday which prohibits pharmacy benefit managers (PBMs) from pocketing the rebates they collect from…
HEALTH
How the FDA, with biotech, is reducing animal testing
While animal activists oppose animal testing on moral grounds, alternative technology can provide more accurate and less expensive screening for experimental drugs, say biotech experts.
AGRICULTURE
CLIMATE CHANGE
It’s World Water Day, and biotech can join in the efforts for cleaner water
It’s World Water Day, and the U.N. encourages everyone to take action in any way possible. And biotechnology has the…
Read more
FEDERAL POLICY
STATE POLICY
4 things for biotech to watch in the 2023 state legislatures
Already, 2023 is looking like a dynamic year for biotech on the state level as state legislatures nationwide get ready…
Read more
INTERNATIONAL
BIO’s VIEW
I am BIO Podcast: Accelerated Approval, accelerating hope
The Accelerated Approval pathway was established by the U.S. Food and Drug Administration (FDA) in the 1990s to boost R&D…
Read more
